Research
Hormonal
Liraglutide, 3.0 mg, is safe with no serious adverse events or treatment-related deaths reported.
Liraglutide can be considered a safe option for weight management in the studied population.
StrongSupportsmedium confidence
There were no serious adverse events and no treatment-related deaths.
Why this rating
Based on a randomized placebo-controlled trial design.
Source
Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery
Jessica Mok et al. · JAMA Surgery · 2023
rct · n=70Cited 148×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →